NCT03595397

Brief Summary

This work aims at comparing the analgesic effect of Thoracic Epidural Magnesium sulfate versus Fentanyl when added as adjuvants to Bupivacaine in patients with multiple traumatic fracture ribs.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

July 1, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 23, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

July 23, 2018

Status Verified

July 1, 2018

Enrollment Period

1 year

First QC Date

July 1, 2018

Last Update Submit

July 12, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in Pain Scores (Visual Analogue pain scale)

    Visual analog scale \[VAS\] is a measure of pain intensity. It is a continuous scale comprised of a horizontal or vertical scale usually 10 cm or 100 mm length. For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 \[on 100-mm scale\]. The pain visual analog scale is self completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity. After the patient has marked, using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark. The scores can be from 0-100. A higher score indicates greater pain intensity. Based on the distribution of pain, the following cut points on the pain VAS have been recommended: No pain (0 -4 mm) Mild pain (5-44 mm) Moderate pain (45-74 mm) Severe pain (75-100 mm)

    48 hours

Secondary Outcomes (5)

  • Development of pulmonary complications: respiratory rate by breath per minute (need for mechanical ventilation)

    48 hours

  • Assessment of parameters of adequate ventilation and oxygenation: PaO2/FIO2 ratio

    48 hours

  • Assessment of parameters of adequate ventilation and oxygenation: PaCO2 in mmHg

    48 hours

  • Changes in heart rate (HR) by beats per minute

    48 hours

  • changes in arterial blood pressure (ABP) by mmHg

    48 hours

Study Arms (3)

Group I

ACTIVE COMPARATOR

20 patients will receive mid-thoracic epidural analgesia with a loading dose of 8 ml of 0.125% bupivacaine, followed by continuous infusion of 8 ml/hour

Drug: BupivacaineProcedure: Thoracic epidural

Group II

ACTIVE COMPARATOR

20 patients will receive mid-thoracic epidural analgesia with a loading dose of 8 ml mixture of 0.125% bupivacaine and 30 mg/kg magnesium sulfate, followed by continuous infusion of 8 ml/hour of a mixture of 0.125% bupivacaine and 20% magnesium sulfate

Drug: Magnesium SulfateProcedure: Thoracic epidural

Group III

ACTIVE COMPARATOR

20 patients will receive mid-thoracic epidural analgesia with a loading dose of 8 ml of 0.125 bupivacaine and 2 mcg/ml fentanyl, followed by continuous infusion of 8 ml/hour

Drug: FentanylProcedure: Thoracic epidural

Interventions

20 patients will receive mid-thoracic epidural analgesia with a loading dose of 8 ml of 0.125% bupivacaine, followed by continuous infusion of 8 ml/hour

Group I

20 patients will receive mid-thoracic epidural analgesia with a loading dose of 8 ml mixture of 0.125% bupivacaine and 30 mg/kg Magnesium Sulfate, followed by continuous infusion of 8 ml/hour mixture of 0.125% bupivacaine and 20% Magnesium sulfate

Also known as: bupivacaine
Group II

20 patients will receive mid-thoracic epidural analgesia with a loading dose of 8 ml of 0.125 bupivacaine and 2 mcg/ml fentanyl, followed by continuous infusion of 8 ml/hour.

Also known as: bupivacaine
Group III

All patients will receive mid-thoracic epidural analgesia

Group IGroup IIGroup III

Eligibility Criteria

Age16 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 16 years of age and greater
  • Non-intubated at the time of block placement
  • Traumatic Rib Fractures two or greater
  • Block must be done within 12-24 hours of presentation to the emergency room
  • ASA physical status: I-II

You may not qualify if:

  • Patient refusal
  • BMI more than 30 kg/m2
  • Need for mechanical ventilation on admission
  • Hemodynamic instability
  • Haemothorax or Pneumothorax
  • Contraindications of performing blocks as coagulopathy, vertebral column deformities, local infection
  • Traumatic head injury
  • Allergy to local anesthetic agents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Gage A, Rivara F, Wang J, Jurkovich GJ, Arbabi S. The effect of epidural placement in patients after blunt thoracic trauma. J Trauma Acute Care Surg. 2014 Jan;76(1):39-45; discussion 45-6. doi: 10.1097/TA.0b013e3182ab1b08.

    PMID: 24368355BACKGROUND
  • Dehghan N, de Mestral C, McKee MD, Schemitsch EH, Nathens A. Flail chest injuries: a review of outcomes and treatment practices from the National Trauma Data Bank. J Trauma Acute Care Surg. 2014 Feb;76(2):462-8. doi: 10.1097/TA.0000000000000086.

    PMID: 24458051BACKGROUND
  • Flagel BT, Luchette FA, Reed RL, Esposito TJ, Davis KA, Santaniello JM, Gamelli RL. Half-a-dozen ribs: the breakpoint for mortality. Surgery. 2005 Oct;138(4):717-23; discussion 723-5. doi: 10.1016/j.surg.2005.07.022.

    PMID: 16269301BACKGROUND
  • Ziegler DW, Agarwal NN. The morbidity and mortality of rib fractures. J Trauma. 1994 Dec;37(6):975-9. doi: 10.1097/00005373-199412000-00018.

    PMID: 7996614BACKGROUND
  • Wu CL, Jani ND, Perkins FM, Barquist E. Thoracic epidural analgesia versus intravenous patient-controlled analgesia for the treatment of rib fracture pain after motor vehicle crash. J Trauma. 1999 Sep;47(3):564-7. doi: 10.1097/00005373-199909000-00025.

    PMID: 10498316BACKGROUND
  • Mackersie RC, Karagianes TG, Hoyt DB, Davis JW. Prospective evaluation of epidural and intravenous administration of fentanyl for pain control and restoration of ventilatory function following multiple rib fractures. J Trauma. 1991 Apr;31(4):443-9; discussion 449-51.

    PMID: 1902264BACKGROUND

MeSH Terms

Interventions

BupivacaineMagnesium SulfateFentanylTea

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesMagnesium CompoundsInorganic ChemicalsSulfatesSulfuric AcidsSulfur AcidsSulfur CompoundsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Central Study Contacts

Ahmed K Fathy, resident

CONTACT

Emad Z Kamel, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 1, 2018

First Posted

July 23, 2018

Study Start

July 1, 2018

Primary Completion

July 1, 2019

Study Completion

August 1, 2019

Last Updated

July 23, 2018

Record last verified: 2018-07